• NYC Planning Council talk by Jules: Aging with HIV in the US & NYC-clinical & community care & services needs, unmet needs - (06/14/21)
   
  
• Medicare PLWH: Blacks & Latinos 4-Fold Greater Risk - (06/14/21)
   
  
• HHS-Older PLWH Reduced Survival by 3.6 times & More Comorbidities - (06/14/21)
   
  
• Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015 - (06/09/21)
   
  
• Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiation - (06/09/21)
   
  
• Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers - (06/09/21)
   
  
• Assessing the health status and mortality of older people over 65 with HIV - greater mortality, more comorbidities - (06/07/21)
   
  
• SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study - (06/05/21)
   
  
• Clinical features and outcomes of COVID-19 among people living with HIV in the United States: A multicenter study from a large global health research network (TriNetX) - PWH had higher rates of poor COVID outcomes - (06/05/21)
   
  
• Bictegravir-Based Antiretroviral Therapy-Associated Accelerated Hyperglycemia and Diabetes Mellitus - (06/05/21)
   
  
• Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial - (06/05/21)
   
  
• HIV/AIDS at 40: COVID Could Increase by 10% Rates in HIV-related Deaths; PLWH with HIV & Undetectable HIV RNA may Experience 13 years Accelerated Aging, Fauci - (06/05/21)
   
  
More HIV Articles...
 

More News Updates Articles...
 

• EASL: HCV Micro-Elimination Funding Grants Available
   
  
• Medicaid Expansion Association with End-Stage Liver Disease Mortality Depends on Leniency of Medicaid Hepatitis C Virus Coverage - (06/13/21)
   
  
• U.S. Food and Drug Administration Approves New Formulation of Epclusa®, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C - (06/11/21)
   
  
• FDA Approves Mavyret (G/P, glecaprevir and pibrentasvir) for Pediatric HCV Treatment 3 Years & Older - (06/11/21)
   
  
• Letter to the Editor: Pregnant women and their providers want DAAs and we are missing the mark - (06/11/21)
   
  
• AASLD: The Future of HCV Vaccine Development - (06/01/21)
   
  
• Cost-effectiveness of Total State Coverage for Hepatitis C Medications - (06/01/21)
   
  
• HIV and Hepatitis C Linkage-to-Care Initiative for New Orleans Residents Experiencing Homelessness During the COVID-19 Pandemic - (06/01/21)
   
  
• HCV Elimination: Universal Routine Screening Should be Mandated - (06/01/21)
   
  
More Hep C Articles...
 

• The times they are a-changing - A refined proposal for finite HBV nucleos(t)ide analog therapy - Expert Opinion - (05/04/21)
   
  
• Risk of Hepatocellular Carcinoma with Hepatitis B Viremia among HIV/Hepatitis B Virus‐Coinfected Persons in North America - (05/03/21)
   
  
• CROI: FREQUENT HBsAg CLEARANCE DURING TENOFOVIR THERAPY IN HIV/ HBV COINFECTION - (03/25/21)
   
  
• CROI: FREQUENT HBsAg CLEARANCE DURING TENOFOVIR THERAPY IN HIV/ HBV COINFECTION - (03/25/21)
   
  
More Hep B Articles...
 

List not necessarily listed here in order of date being held.